Compass Diversified (CODI) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Achieved double-digit revenue growth in Q3 2024, with net sales up 11.8% to $582.6M, driven by strong branded consumer performance, including Lugano, BOA, and The Honey Pot Co., and stabilization in industrial businesses.
Adjusted EBITDA reached a record $114M in Q3 2024, up 28% year-over-year, and adjusted earnings rose 65% to $48.7M.
Net income from continuing operations was $31.5M in Q3 2024, reversing a prior year loss.
Raised full-year 2024 guidance based on strong performance and positive business momentum.
Awarded Inc. Magazine's Founder-Friendly Investor Award, highlighting collaborative approach with subsidiaries.
Financial highlights
Q3 2024 consolidated net sales were $582.6M, up 11.8% year-over-year; pro forma sales grew 6.6%.
Q3 2024 gross profit margin improved to 47.1% from 43.2% in Q3 2023.
Q3 2024 net income was $31.5M, compared to a net loss of $3.8M in Q3 2023.
Adjusted EBITDA for Q3 2024 was $114M, a 28% increase year-over-year.
Ended Q3 with $71.9M in cash and over $480M available on revolver; total leverage ratio at 3.68x.
Outlook and guidance
Raised full-year 2024 guidance: consolidated pro forma subsidiary adjusted EBITDA expected between $510M–$525M, including The Honey Pot Co.
Branded consumer vertical adjusted EBITDA expected at $390M–$400M; industrial vertical at $120M–$125M.
Consolidated adjusted EBITDA expected between $420M–$435M; adjusted earnings between $155M–$165M.
Guidance includes The Honey Pot Company for the full year 2024 and excludes impact of future acquisitions or divestitures.
Latest events from Compass Diversified
- Core subsidiaries delivered revenue and EBITDA growth in 2025 despite Lugano-related disruption.CODI
Q4 202526 Feb 2026 - High-growth, innovative portfolio and disciplined strategy target $1B+ EBITDA by 2028.CODI
Investor Day 20253 Feb 2026 - Branded consumer strength drove 11% sales growth and 27% higher Adjusted EBITDA in Q2 2024.CODI
Q2 20242 Feb 2026 - $380M acquisition of a high-growth feminine care brand closing February 2024.CODI
Investor update16 Jan 2026 - Q3 sales up 3.5%, but net loss widened and liquidity risks remain amid ongoing uncertainties.CODI
Q3 202514 Jan 2026 - Q2 2025 revenue up 12.2%, net loss narrows, but risks remain from Lugano and litigation.CODI
Q2 202529 Dec 2025 - Revenue and margin gains offset by ongoing legal and going concern risks.CODI
Q1 202518 Dec 2025 - Lugano fraud drives restatement, loss, and restructuring; core businesses show resilient growth.CODI
Status Update6 Dec 2025 - Strong 2024 growth, governance reforms, and key votes set for the 2025 virtual annual meeting.CODI
Proxy Filing1 Dec 2025